News & Alerts
-
Jun- 2024 -18 June
FDA Places Zentalis’ Cancer Drug Studies on Partial Hold After Patient Deaths
June 18, 2024 – The U.S. Food and Drug Administration (FDA) has placed three studies of Zentalis Pharmaceuticals’ cancer drug,…
Read More » -
15 June
Ascentage Pharma and Takeda Sign $1.3 Billion Global Licensing Agreement for Cancer Drug
Ascentage Pharma, a leading global biopharmaceutical company, has entered into an option agreement with Takeda, a prominent global biopharmaceutical firm.…
Read More » -
May- 2024 -20 May
KAV Health Group Launches Innovative Mental Health Day Treatment Program in Dayton
KAV Health Group, LLC, a premier provider of comprehensive mental health services, is excited to announce the opening of its…
Read More » -
17 May
Advancements in Robotic Scripts for Biological Laboratory Automation
The modern biological lab hums with a constant undercurrent of activity – a symphony of discovery where groundbreaking research unfolds…
Read More » -
14 May
Implantica Announces the Eighth RefluxStop™ Center of Excellence in Italy
Implantica AG (publ.), a pioneering medtech company, has unveiled a significant milestone with the establishment of a new hospital performing…
Read More » -
14 May
Essity Invests in New R&D Center in France: Advancing Innovation in Tissue Hygiene Products
Essity, a leading hygiene and health company, has announced its investment in a cutting-edge global center for research and development…
Read More » -
14 May
FDA Accepts Sumitomo’s Vibegron Application for Overactive Bladder in Men with BPH Therapy
Sumitomo Pharma America, Inc. (SMPA) declared a significant development today as the U.S. Food and Drug Administration (FDA) accepted its…
Read More » -
Apr- 2024 -29 April
Laekna, Inc. Releases 2023 ESG Report: A Testament to Sustainable Growth and Corporate Responsibility
Laekna, Inc. (2105.HK), a prominent player in the biotechnology and drug development landscape, unveiled its highly anticipated 2023 Environmental, Social,…
Read More » -
25 April
Merck & Co. Ups 2024 Profit Forecast Amidst Stellar Drug Sales Performance
Merck & Co. has announced an upward revision of its 2024 profit forecast, citing robust sales performance for its flagship…
Read More » -
24 April
Global HIV Drugs Market: Forecasted Growth and Key Players in the Fight Against HIV/AIDS
The global HIV drugs market is poised for significant growth, with Technavio projecting a substantial increase in market size by…
Read More »
